论文部分内容阅读
1 临床资料 95例均为住院患者,诊断符合1995年5月北京第5次全国传染病与寄生虫病会议修订的病毒性肝炎标准。随机分成两组:治疗组45例,男38例,女7例,年龄20～62岁,平均36.5岁;病程7天～4月,平均26天;ALT72～3062U/L,平均485U/L;AST43～2521U/L,平均414U/L;TBil 175.3～468.8μmol/L,平均239.6±45.9μmol/L;甲型3例,乙型15例,戊型9例,甲+乙11例,甲+戊1例,乙+戊6例。对照组50例,男40例,女10例;年龄4～66岁,平均32.2岁;病程5天～3月,平均24天;ALT43～2581U/L,平均462U/L;AST33～1627U/L,平均442U/L;TBil178.6～413.8μmol/L,平均226.7±40.7μmol/L;甲型4例,乙型16例,戊型8例,甲+乙10例,乙+戊11例,TTV1例。两组临床资料比较,无显著差异(P>0.05),具有可比性。
1 95 cases of clinical data were hospitalized patients, the diagnosis of line with the 1995 May Beijing 5th National Infectious Diseases and Parasitic Diseases meeting revised viral hepatitis standards. The patients in the treatment group were divided into two groups at random: treatment group 45 cases, 38 males and 7 females, aged from 20 to 62 years with an average of 36.5 years old. The course of disease ranged from 7 days to April, with an average of 26 days. ALT ranged from 72 to 3062U / L with an average of 485U / AST43 ~ 2521U / L, an average of 414U / L; TBil 175.3 ~ 468.8μmol / L, an average of 239.6 ± 45.9μmol / L; 3 cases of type A, 15 cases of type B, 9 cases of type E, E 1 case, B + E 6 cases. The control group of 50 patients, 40 males and 10 females; aged 4 to 66 years, mean 32.2 years; duration of 5 days to March, an average of 24 days; ALT43 ~ 2581U / L, an average of 462U / L; AST33 ~ 1627U / L , An average of 442U / L; TBil176.6 ~ 413.8μmol / L, an average of 226.7 ± 40.7μmol / L; type A in 4 cases, type B in 16 cases, type E in 8 cases, TTV1 cases. The two groups of clinical data, no significant difference (P> 0.05), comparable.